Connection
Michael Clay to Receptor, Platelet-Derived Growth Factor beta
This is a "connection" page, showing publications Michael Clay has written about Receptor, Platelet-Derived Growth Factor beta.
|
|
Connection Strength |
|
|
|
|
|
0.181 |
|
|
|
-
Eissa SS, Clay MR, Santiago T, Wu G, Wang L, Shulkin BL, Picarsic J, Nichols KE, Campbell PK. Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion. Blood Adv. 2020 07 14; 4(13):2991-2995.
Score: 0.181